Last mentioned: Mar 18, 2026
PDUFA Date
Target date for FDA decision on INO-3107 accelerated approval.
Inovio PDUFA Date
Target date for FDA decision on INO-3107 biologics license application.
Platform Modernization
LivePerson expects to complete its multiyear platform modernization.
Q1 2026 Target
Identiv aims to hit 26%-35% sales growth driven by BLE smart label demand.
Earnings Call
Q4 2025 results released, detailing growth targets and AI security roadmaps.
Q4 2025 Earnings
Both companies release full Q4 2025 transcripts and 2026 outlooks.
Syntrix Launch
LivePerson details $195M-$207M revenue target alongside Syntrix platform launch.
Growth Targets Set
Identiv outlines aggressive 26-35% growth target for Q1 2026.
BLA Acceptance
FDA accepts Inovio's BLA for INO-3107 under accelerated approval program.
LivePerson Syntrix Launch
Full commercial availability of Syntrix platform announced for enterprise banking and tech.
Industry Recognition
LivePerson named a leader in Aragon Research Globe for Agent Platforms.
Bakkt Capital Raise
Registered direct offering raises $48.1 million to bolster cash reserves.
Q4 2025 Close
Identiv and LivePerson conclude their first full fiscal year under new strategic mandates.
Bakkt Debt Extinguished
Company completes the elimination of all long-term debt and simplifies cap table.
Inovio Cash Position
Company ends the year with $94.1 million in cash.
Strategic Divestiture
Identiv announces the sale of its physical security business to Vitaprotech.
LivePerson reported Q4 2025 earnings beating expectations, driven by a significant shift toward generative AI integration across its conversational platform. While the company faces sequential revenue declines, the launch of the Syntrix platform and strong adoption of AI-powered tools signal a fundamental transition in its business model.
LivePerson exceeded Q4 2025 expectations with $59.3 million in revenue and $10.8 million in Adjusted EBITDA, driven by the commercial launch of its Syntrix platform and aggressive cost discipline. While total revenue continues a sequential decline due to legacy churn, the company is betting on a unified AI architecture and high-value enterprise expansions to return to growth by late 2026.
Bakkt reported a revenue decline to $2.3 billion following a restructured Webull agreement but achieved a debt-free balance sheet and expanded into stablecoin settlement. Meanwhile, LivePerson saw 20% of customer interactions driven by generative AI as it launched its Syntrix platform, signaling a broader shift toward high-utility infrastructure.
LivePerson, Inovio, and Bakkt reported Q4 2025 results highlighting strategic transitions toward AI integration, regulatory milestones, and balance sheet restructuring. While LivePerson capitalizes on generative AI adoption and Inovio nears a critical FDA PDUFA date, Bakkt has streamlined its capital structure to focus on institutional crypto services.
Inovio Pharmaceuticals faces a critical regulatory juncture as the FDA accepts its BLA for INO-3107 while questioning its accelerated approval eligibility. Meanwhile, LivePerson is pivoting toward a unified AI architecture with the launch of its Syntrix platform, signaling a shift in how healthcare enterprises may manage patient engagement.
Identiv and LivePerson reported Q4 2025 results, highlighting a strategic shift toward AI-integrated security and conversational automation. While Identiv focuses on the intersection of physical security and AI analytics, LivePerson is doubling down on generative AI to drive enterprise-scale customer engagement.
Identiv and LivePerson reported Q4 2025 results that underscore a strategic shift toward specialized high-growth sectors. Identiv is aggressively targeting the BLE smart label market, while LivePerson is banking on its new Syntrix AI platform and expanded Google partnership to drive 2026 revenue.
Identiv and LivePerson reported Q4 2025 results, highlighting strategic shifts toward specialized high-margin technologies. Identiv is betting on Bluetooth Low Energy (BLE) smart labels for 2026 growth, while LivePerson is leveraging its new Syntrix platform and an expanded Google partnership to stabilize revenue.
Identiv and LivePerson reported Q4 2025 earnings, highlighting a strategic shift toward digital identity and secure AI. Identiv set aggressive 2026 growth targets driven by its BLE smart label expansion, while LivePerson continues to navigate the security-first enterprise AI landscape.
Identiv and LivePerson's Q4 2025 results reveal a strategic pivot toward integrated consumer experiences, combining Bluetooth-enabled smart packaging with generative AI conversational platforms. As Identiv targets aggressive growth in BLE smart labels, LivePerson is scaling its Syntrix AI engine through an expanded Google partnership to redefine brand-to-consumer engagement.